The Justice Department announced that Quest Diagnostics will pay more than $13 million to resolve allegations that it provided illegal remuneration to physicians and healthcare executives in violation of the Anti-Kickback Statute. According to the announcement, the alleged inducements were tied to referrals for laboratory testing and implicated federally funded healthcare programs. The case highlights continued federal scrutiny of financial arrangements that may distort medical judgment and increase costs to Medicare and other public programs.
